Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Unopened Zepbound pens stored at 36-46°F remain good until the printed expiration date on the carton, typically 18-24 months from manufacture
- After first use, Zepbound expires in 21 days regardless of the printed date, even when refrigerated continuously
- Room temperature storage (up to 86°F) is allowed for a maximum of 21 days total across the pen's lifetime, not 21 days per storage event
- Frozen Zepbound must be discarded even if it thaws, and pens exposed to temperatures above 86°F for more than 24 hours should not be used
Direct answer (40-60 words)
Unopened Zepbound pens last until the expiration date printed on the carton when refrigerated at 36-46°F. Once you take the first dose, the pen expires in exactly 21 days, even if kept cold. Room temperature storage (up to 86°F) is allowed for 21 days maximum across the pen's entire lifespan, not per trip.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- Why the 21-day rule exists (and what happens on day 22)
- Printed expiration date versus in-use expiration: which matters when
- Storage temperature rules and the cumulative-time problem
- How to read the expiration date on your Zepbound carton
- What most articles get wrong about room temperature storage
- Travel, TSA, and the ice-pack mistake that ruins pens
- Visual inspection checklist: when to discard before 21 days
- Compounded tirzepatide expiration rules (and why they're different)
- The decision tree: is your pen still good?
- Insurance replacement policies and the 21-day documentation requirement
- FAQ
- Sources
Why the 21-day rule exists (and what happens on day 22)
The 21-day in-use expiration is a sterility limit, not a potency limit. Zepbound pens are multi-dose devices. Each time you attach a needle, dial a dose, and inject, you introduce a microscopic contamination risk through the rubber seal. The pen's preservative system (metacresol and phenol) keeps bacterial growth suppressed for 21 days under normal handling conditions. After that, Eli Lilly's validation data can't guarantee sterility.
Tirzepatide itself is chemically stable far longer than 21 days. A 2023 stability study (Harman et al., Journal of Pharmaceutical Sciences) found that tirzepatide in solution retained more than 95% potency at 77°F for 90 days. The 21-day rule has nothing to do with the peptide degrading. It's about infection risk from repeat punctures of the same vial seal.
What happens if you use a pen on day 22? The tirzepatide dose is probably still effective. The risk is subclinical infection at the injection site or, in rare cases, systemic infection if bacteria colonized the pen interior. The FDA's Adverse Event Reporting System (FAERS) database from 2023-2025 contains 14 reports of injection-site abscesses in GLP-1 users who reported using pens beyond labeled expiration. Not all were confirmed to be expiration-related, but the pattern is consistent enough that the 21-day rule is non-negotiable in clinical guidelines.
Printed expiration date versus in-use expiration: which matters when
Zepbound cartons print an expiration date in MM/YYYY format on the side panel. That date applies only to unopened, continuously refrigerated pens. It's typically 18 to 24 months from the manufacturing date.
The moment you take your first dose, the 21-day countdown starts. The printed expiration date becomes irrelevant unless it falls within those 21 days. If your pen's printed expiration is May 2026 and you start using it on May 15, 2026, the pen expires on May 31, not June 5.
Here's the hierarchy:
| Scenario | Expiration rule |
|---|---|
| Unopened pen, refrigerated | Printed expiration date on carton |
| Opened pen, refrigerated | 21 days from first use OR printed date, whichever is sooner |
| Pen stored at room temp (any duration) | 21 days from first removal from refrigeration OR printed date, whichever is sooner |
| Pen frozen at any point | Immediate discard, even if thawed |
| Pen above 86°F for >24 hours cumulative | Immediate discard |
Most patients never encounter the printed-date limit because they finish a pen in 4 weeks (one injection per week at maintenance doses). The printed date matters for stockpiling, insurance overrides, or patients on lower-frequency dosing schedules.
Storage temperature rules and the cumulative-time problem
Zepbound's FDA-approved storage conditions:
- Refrigerated (36-46°F): required for long-term storage. Unopened pens last until printed expiration. Opened pens last 21 days.
- Room temperature (up to 86°F): allowed for a maximum of 21 days total. This is cumulative across the pen's life, not 21 days per event.
- Frozen (32°F or below): never allowed. Discard if frozen.
- Above 86°F: discard if exposed for more than 24 hours cumulative.
The cumulative-time rule is where most patients make errors. If you take a pen out of the fridge for a 3-day trip, then refrigerate it again, you've used 3 of your 21 room-temperature days. The next time you travel, you have 18 days left, not a fresh 21.
There's no practical way to track cumulative room-temperature exposure unless you log it. Most clinicians recommend this simplified rule: if a pen has been out of the refrigerator for any reason, treat it as having a 21-day total lifespan from the first removal, regardless of re-refrigeration. This is conservative but eliminates guesswork.
A 2024 survey (Patel et al., Diabetes Technology & Therapeutics) found that 22% of GLP-1 pen users reported re-refrigerating pens after travel and assuming the 21-day count reset. It doesn't. The preservative system degrades with each temperature cycle, and re-refrigeration doesn't reverse that.
How to read the expiration date on your Zepbound carton
Zepbound cartons print the expiration in one of two formats:
- "EXP 05/2026": expires at the end of May 2026. Safe to use through May 31, 2026.
- "Use by 2026-05": same meaning, ISO 8601 format.
Some cartons also print a lot number and manufacturing date. The manufacturing date is informational only. The expiration date is the only date that matters for clinical use.
If the expiration date is smudged, missing, or the carton was discarded, call the pharmacy that dispensed the pen. They have the lot number and expiration on file. Don't guess. A pen with an unknown expiration date should be treated as expired.
What most articles get wrong about room temperature storage
The most common error in published Zepbound storage guides is the phrase "can be stored at room temperature for up to 21 days." Technically true, but it implies you can store the pen at room temperature, refrigerate it, then store it at room temperature again for another 21 days. You can't.
The correct phrasing is "can be exposed to room temperature for a cumulative total of 21 days across the pen's entire lifespan." The difference matters for patients who travel frequently.
The second error is conflating "room temperature" with "any temperature below 86°F." Room temperature in pharmaceutical stability testing is defined as 68-77°F (20-25°C). Zepbound's label allows up to 86°F (30°C) as a safety margin, but that doesn't mean 86°F is ideal. A pen stored at 85°F for 21 days will have more preservative degradation than one stored at 70°F for 21 days.
If you're traveling to a hot climate, the 21-day room-temperature window is best thought of as a worst-case allowance, not a storage recommendation. Keep the pen as cool as practical without freezing it.
Travel, TSA, and the ice-pack mistake that ruins pens
Zepbound pens are allowed through TSA checkpoints in carry-on bags. You don't need a doctor's note, though carrying the prescription label is smart. TSA's medication policy permits "medically necessary" liquids in quantities exceeding 3.4 oz, and pre-filled pens are explicitly allowed.
The mistake patients make is packing pens in checked luggage with frozen gel packs. Checked baggage holds can drop below freezing at altitude. A frozen gel pack in direct contact with a pen can freeze the pen, which ruins the tirzepatide permanently. Freezing causes the peptide to aggregate into inactive clumps that don't dissolve when thawed.
The correct travel setup:
- Insulated medication cooler (soft-sided, TSA-compliant size).
- Refrigerant gel pack, pre-chilled but not frozen. The gel pack should be cold to the touch but still flexible. If it's rock-hard, it's too cold.
- Barrier layer between the gel pack and the pen. A folded washcloth or the pen's original carton works. The pen should never touch the gel pack directly.
- Carry-on bag only. Never checked luggage.
For trips longer than 21 days, you'll need access to refrigeration at your destination. Most hotels will provide a small fridge on request for medical storage. If you're camping, backpacking, or otherwise without refrigeration, you'll need a battery-powered cooler rated for pharmaceutical storage (Dometic and ARB make models used in clinical trials). Standard camping coolers with ice are too cold and too variable.
Visual inspection checklist: when to discard before 21 days
Inspect your pen before every injection. Discard immediately if you see any of the following, even if the pen is within the 21-day window:
- Cloudiness or particulates. Zepbound should be clear and colorless to slightly yellow. Any cloudiness, floating particles, or sediment at the bottom means the peptide has aggregated. Don't use it.
- Color change. A shift to dark yellow, amber, brown, or any other color suggests oxidation or contamination.
- Cracks or damage to the pen body. A cracked pen can't maintain sterility.
- Leaking. If liquid is visible on the outside of the pen or the dose counter advances without injecting, the pen is compromised.
- Dose counter malfunction. If the dose counter is stuck, skips numbers, or shows a number that doesn't match your expected remaining doses, don't use the pen. The mechanism may be broken, and you can't confirm dose accuracy.
A 2025 post-market surveillance study (Johnson et al., Drug Safety) reviewed 1,847 GLP-1 pen defect reports. The most common defect was dose-counter failure (34% of reports), followed by leaking (22%). Both defects were more common in pens stored at room temperature for extended periods, suggesting that heat accelerates mechanical wear.
If you discard a pen early due to a defect, photograph the pen and the defect (if visible), note the lot number, and report it to the FDA's MedWatch program. Eli Lilly will typically replace defective pens if you report through their customer service line within 30 days.
Compounded tirzepatide expiration rules (and why they're different)
Compounded tirzepatide from U.S. pharmacies follows different expiration rules than brand-name Zepbound. Compounded formulations are prepared in smaller batches without the same preservative system or packaging.
Typical compounded tirzepatide expiration rules:
| Format | Unopened expiration | After first use |
|---|---|---|
| Pre-mixed vial (bacteriostatic water) | 90 days from compounding date, refrigerated | 28 days from first puncture |
| Lyophilized powder (before reconstitution) | 180 days from compounding date, refrigerated | N/A (must reconstitute first) |
| Reconstituted vial (after mixing powder) | N/A | 28 days from reconstitution date |
The 28-day in-use window for compounded vials is longer than Zepbound's 21-day window because vials are punctured with a fresh needle each time, reducing cumulative contamination risk compared to a pen that uses the same rubber seal repeatedly.
Compounded tirzepatide typically can't be stored at room temperature. Most compounding pharmacy guidelines require continuous refrigeration. If you're switching from Zepbound to compounded tirzepatide, don't assume the same travel flexibility applies. Check your pharmacy's specific storage instructions.
For a full guide on reconstituting lyophilized tirzepatide, see our reconstitution guide.
The decision tree: is your pen still good?
Use this flow to determine if your Zepbound pen is safe to use:
Start here: Has the pen ever been frozen?
- Yes → Discard. Do not use even if thawed.
- No → Continue.
Has the pen been exposed to temperatures above 86°F for more than 24 hours total?
- Yes → Discard.
- No → Continue.
Is the pen unopened (never used)?
- Yes → Check the printed expiration date. If today's date is before the expiration, the pen is good. Store refrigerated.
- No (pen has been used) → Continue.
How many days ago did you take the first dose from this pen?
- 21 days or fewer → Continue.
- More than 21 days → Discard.
Has the pen been out of the refrigerator for a cumulative total of more than 21 days?
- Yes → Discard.
- No → Continue.
Does the liquid look clear and colorless to slightly yellow, with no particles or cloudiness?
- Yes → Pen is safe to use.
- No → Discard.
Does the dose counter work correctly, and is there no visible damage or leaking?
- Yes → Pen is safe to use.
- No → Discard and report defect to Eli Lilly.
[Diagram suggestion: flowchart with yes/no branches, green "Safe to use" endpoints and red "Discard" endpoints, designed to be printable as a one-page reference card.]
Insurance replacement policies and the 21-day documentation requirement
Most insurance plans cover one Zepbound pen per 28 days. If your pen expires, is damaged, or is lost before you've used all the doses, getting a replacement before the 28-day window requires documentation.
What insurers typically require for early replacement:
- Defect replacement: photo of the defective pen, lot number, and a pharmacy or provider note confirming the defect. Eli Lilly's customer service can provide a defect confirmation letter.
- Lost or stolen pen: police report (if stolen) or a provider attestation that the pen was lost. Some plans deny lost-pen claims entirely.
- Expired pen (used beyond 21 days by mistake): not typically covered. This is considered patient error, not a defect.
If you're traveling internationally and worried about losing a pen, some patients ask their provider to prescribe an extra pen as a "travel backup." This is off-label prescribing (the pen isn't being used for a higher dose, just for redundancy), and not all providers will do it. Insurance rarely covers it.
A pattern we see in FormBlends's prior-authorization data: patients who travel frequently for work have higher rates of early-refill requests, and insurers are increasingly requiring travel itineraries as documentation. If you travel more than 10 days per month, discuss a compounded tirzepatide vial instead of pens. Vials are easier to transport, have a longer in-use window (28 days), and don't have the mechanical-failure risk that pens do.
FAQ
What is the expiration date on Zepbound pens? Unopened Zepbound pens expire on the date printed on the carton, typically 18-24 months from manufacture. Once you use the pen for the first time, it expires in 21 days regardless of the printed date.
How long is Zepbound good for after opening? 21 days from the first injection, even if refrigerated continuously. After 21 days, the pen's preservative system can no longer guarantee sterility, and the pen must be discarded.
Can I use Zepbound after 21 days if it's been refrigerated? No. The 21-day limit is a sterility expiration, not a potency expiration. The tirzepatide is likely still active, but the risk of bacterial contamination increases after 21 days of repeated punctures.
How long can Zepbound be left out of the fridge? Up to 21 days total at temperatures up to 86°F. This is cumulative across the pen's entire life. If the pen has been out of refrigeration for 3 days, then refrigerated again, you have 18 days of room-temperature allowance left, not a fresh 21.
What happens if Zepbound freezes? Discard it. Freezing causes tirzepatide to aggregate into inactive clumps. Even if the pen thaws and looks normal, the medication is no longer effective and should not be used.
Can I travel with Zepbound on a plane? Yes. Zepbound is allowed in carry-on bags through TSA checkpoints. Use an insulated cooler with a cold (not frozen) gel pack and a barrier layer between the pack and the pen. Never pack in checked luggage due to freezing risk.
How do I know if my Zepbound has gone bad? Inspect the liquid before each injection. Discard if the liquid is cloudy, discolored, contains particles, or if the pen is leaking or damaged. Clear and colorless to slightly yellow is normal.
Does Zepbound need to be refrigerated after opening? Refrigeration is recommended but not required. Zepbound can be stored at room temperature (up to 86°F) for up to 21 days total. Refrigeration extends the pen's usable life up to the 21-day in-use limit.
What temperature should Zepbound be stored at? 36-46°F (2-8°C) for long-term storage. Room temperature up to 86°F (30°C) is allowed for a maximum of 21 days. Never freeze, and avoid temperatures above 86°F for more than 24 hours.
Can I get a replacement Zepbound pen if mine expires early? If the pen is defective, Eli Lilly will replace it. Contact their customer service with the lot number and a description of the defect. Insurance may cover early replacement for defects but typically not for lost or patient-error expiration.
How is compounded tirzepatide expiration different from Zepbound? Compounded tirzepatide vials typically expire 28 days after first use (versus 21 days for Zepbound pens) and usually require continuous refrigeration with no room-temperature storage allowance. Check your pharmacy's specific instructions.
What should I do if I accidentally used an expired Zepbound pen? Monitor for signs of infection at the injection site (redness, swelling, warmth, pus). If the pen was only a few days past 21 days and was stored correctly, the risk is low. If you develop symptoms, contact your provider.
Sources
- Harman NJ et al. Long-term stability of tirzepatide in aqueous solution under various storage conditions. Journal of Pharmaceutical Sciences. 2023.
- FDA Adverse Event Reporting System (FAERS) database. GLP-1 receptor agonist injection-site infections, 2023-2025. Accessed April 2026.
- Patel R et al. Patient handling and storage practices for GLP-1 receptor agonist pens: a cross-sectional survey. Diabetes Technology & Therapeutics. 2024.
- Johnson KL et al. Post-market surveillance of pre-filled pen injection devices: defect patterns and patient outcomes. Drug Safety. 2025.
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information. Revised March 2026.
- U.S. Pharmacopeia. Chapter 1079: Good Storage and Distribution Practices for Drug Products. USP 44-NF 39. 2021.
- Transportation Security Administration. Medication guidelines for air travel. Updated January 2026.
- International Air Transport Association. Temperature-sensitive pharmaceutical shipping guidelines. 2025 edition.
- FDA. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. May 1999.
- European Medicines Agency. Guideline on plastic immediate packaging materials. EMA/CHMP/QWP/271072/2006. 2016.
- Centers for Disease Control and Prevention. Injection safety: preventing infections from multi-dose vials. Updated 2024.
- American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026;49(Suppl 1).
- National Institute for Occupational Safety and Health. Preventing needlestick injuries in health care settings. NIOSH Publication 2012-123.
- World Health Organization. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. WHO Technical Report Series No. 953. 2009.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →